
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18232148
[patent_doc_number] => 11596692
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-03-07
[patent_title] => PD-L1/STING conjugates and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/691150
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 83015
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691150 | PD-L1/STING conjugates and methods of use | Nov 20, 2019 | Issued |
Array
(
[id] => 15649565
[patent_doc_number] => 20200087312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => MACROCYCLES AS FACTOR XIA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/691099
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 315
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691099 | Macrocycles as factor XIA inhibitors | Nov 20, 2019 | Issued |
Array
(
[id] => 15646529
[patent_doc_number] => 20200085794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => RILUZOLE PRODRUGS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/689150
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689150 | Riluzole prodrugs and their use | Nov 19, 2019 | Issued |
Array
(
[id] => 17314397
[patent_doc_number] => 20210403445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES
[patent_app_type] => utility
[patent_app_number] => 17/293424
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293424 | SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES | Nov 17, 2019 | Abandoned |
Array
(
[id] => 17335953
[patent_doc_number] => 20220002284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PESTICIDAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/291402
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291402 | Pesticidal compounds | Nov 17, 2019 | Issued |
Array
(
[id] => 17133692
[patent_doc_number] => 11135227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Oxygen linked pyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/677080
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25876
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16677080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/677080 | Oxygen linked pyrimidine derivatives | Nov 6, 2019 | Issued |
Array
(
[id] => 17258411
[patent_doc_number] => 20210371396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => 1,4-DIAZOCANE COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/290306
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290306 | 1,4-diazocane compound or salt thereof | Oct 31, 2019 | Issued |
Array
(
[id] => 17303389
[patent_doc_number] => 20210399228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOUND, PRODUCTION METHOD THEREFOR, AND ORGANIC SEMICONDUCTOR MATERIAL OBTAINED USING SAID COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/288949
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288949 | Compound, production method therefor, and organic semiconductor material obtained using said compound | Oct 24, 2019 | Issued |
Array
(
[id] => 16673036
[patent_doc_number] => 20210061799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => 11-ARYLCINNOLINO[2,3-f]PHENANTHRIDINIUM SALTS AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/664370
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/664370 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same | Oct 24, 2019 | Issued |
Array
(
[id] => 15797327
[patent_doc_number] => 20200121806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/663251
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16663251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/663251 | Maytansinoid derivatives, conjugates thereof, and methods of use | Oct 23, 2019 | Issued |
Array
(
[id] => 16973880
[patent_doc_number] => 11069863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Organic thin film and organic thin film transistor and electronic device
[patent_app_type] => utility
[patent_app_number] => 16/661631
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 13085
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661631 | Organic thin film and organic thin film transistor and electronic device | Oct 22, 2019 | Issued |
Array
(
[id] => 15496153
[patent_doc_number] => 20200048265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/656328
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/656328 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Oct 16, 2019 | Abandoned |
Array
(
[id] => 15454331
[patent_doc_number] => 20200039990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
[patent_app_type] => utility
[patent_app_number] => 16/598876
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598876 | Short-acting benzodiazepine salts and their polymorphic forms | Oct 9, 2019 | Issued |
Array
(
[id] => 18124015
[patent_doc_number] => 20230009626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/282432
[patent_app_country] => US
[patent_app_date] => 2019-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282432
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282432 | INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS | Oct 6, 2019 | Abandoned |
Array
(
[id] => 15681131
[patent_doc_number] => 20200095229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => Purified cenicriviroc and purified intermediates for making cenicriviroc
[patent_app_type] => utility
[patent_app_number] => 16/561969
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16561969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/561969 | Purified cenicriviroc and purified intermediates for making cenicriviroc | Sep 4, 2019 | Abandoned |
Array
(
[id] => 15363415
[patent_doc_number] => 20200017472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => N-SUBSTITUTED SULFONAMIDE COMPOUND AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/556978
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556978 | Crystal of N-substituted sulfonamide compound | Aug 29, 2019 | Issued |
Array
(
[id] => 15813885
[patent_doc_number] => 10632099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Non-aromatic difluoro analogues of resorcylic acid lactones
[patent_app_type] => utility
[patent_app_number] => 16/556626
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18297
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 479
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556626 | Non-aromatic difluoro analogues of resorcylic acid lactones | Aug 29, 2019 | Issued |
Array
(
[id] => 16519452
[patent_doc_number] => 10870662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
[patent_app_type] => utility
[patent_app_number] => 16/555741
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14619
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555741 | Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia | Aug 28, 2019 | Issued |
Array
(
[id] => 15586223
[patent_doc_number] => 20200069646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/555634
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555634 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | Aug 28, 2019 | Issued |
Array
(
[id] => 19372873
[patent_doc_number] => 12064412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Method for preparing solution formulation for aerosol inhalation of naringenin
[patent_app_type] => utility
[patent_app_number] => 16/976728
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3447
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976728 | Method for preparing solution formulation for aerosol inhalation of naringenin | Aug 27, 2019 | Issued |